|Articles|August 17, 2014
The Future of Oncology is Now
Author(s)Guest Blogger
Applied Clinical Trials’ Lisa Henderson speaks to Novella Clinical CEO Richard Staub.
Advertisement
Applied Clinical Trials’ Lisa Henderson speaks to Novella Clinical CEO Richard Staub.
Last August, Quintiles announced its intention to purchase Novella Clinical, specifically for its focus on small and mid-sized oncology biopharma clients, as well as medical device and diagnostics companies. We checked in with Novella President Richard Staub to discuss post-acquisition life, outsourcing, and emerging trends in oncology.
For this article,
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Pharma M&A Roundup: Incyte to Acquire Vega Therapeutics, Galmed Pharmaceuticals to Acquire Colospan, Johnson & Johnson Acquires Firefly Bio
2
Beyond JAK Inhibitors: Biologics Signal a New Era in Alopecia Areata
3
Deepening Ties: Why China is Becoming Big Pharma's Most Essential R&D Partner
4
Pharmaceutical Executive Daily: Roche and Nurix Therapeutics Announce Global Collaboration
5